Jane Jijun Liu

963 total citations
23 papers, 405 citations indexed

About

Jane Jijun Liu is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Jane Jijun Liu has authored 23 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Oncology. Recurrent topics in Jane Jijun Liu's work include Acute Myeloid Leukemia Research (6 papers), Palliative Care and End-of-Life Issues (5 papers) and Frailty in Older Adults (4 papers). Jane Jijun Liu is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Palliative Care and End-of-Life Issues (5 papers) and Frailty in Older Adults (4 papers). Jane Jijun Liu collaborates with scholars based in United States, Australia and Mexico. Jane Jijun Liu's co-authors include Martine Extermann, Rami S. Komrokji, Jeffrey E. Lancet, Kah Poh Loh, Marie Flannery, Eva Culakova, Jodi Geer, Jingsong Zhang, Lynn C. Moscinski and Supriya G. Mohile and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Jane Jijun Liu

21 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Jijun Liu United States 12 172 89 75 74 67 23 405
Andrew Hantel United States 12 119 0.7× 117 1.3× 34 0.5× 77 1.0× 123 1.8× 60 499
Lee Mozessohn Canada 10 93 0.5× 37 0.4× 37 0.5× 74 1.0× 67 1.0× 50 363
Pascal Chaı̈bi France 12 165 1.0× 66 0.7× 75 1.0× 60 0.8× 147 2.2× 33 528
Benjamin Barnes Germany 13 257 1.5× 121 1.4× 22 0.3× 60 0.8× 86 1.3× 29 530
Roberta Babare Italy 8 192 1.1× 55 0.6× 134 1.8× 142 1.9× 106 1.6× 13 597
Sara Ekberg Sweden 15 197 1.1× 67 0.8× 45 0.6× 221 3.0× 23 0.3× 50 514
C.A. Uyl-de Groot Netherlands 12 258 1.5× 78 0.9× 18 0.2× 116 1.6× 118 1.8× 28 553
O. Gisserot France 8 125 0.7× 51 0.6× 111 1.5× 40 0.5× 129 1.9× 54 567
Karen Sweiss United States 13 145 0.8× 61 0.7× 25 0.3× 55 0.7× 305 4.6× 83 578

Countries citing papers authored by Jane Jijun Liu

Since Specialization
Citations

This map shows the geographic impact of Jane Jijun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Jijun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Jijun Liu more than expected).

Fields of papers citing papers by Jane Jijun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Jijun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Jijun Liu. The network helps show where Jane Jijun Liu may publish in the future.

Co-authorship network of co-authors of Jane Jijun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Jijun Liu. A scholar is included among the top collaborators of Jane Jijun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Jijun Liu. Jane Jijun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
DeZern, Amy E., Michael Otterstatter, Nancy Gillis, et al.. (2024). Progression of Myelodysplastic Syndromes in the MDS Natural History Study (MDS NHS). Blood. 144(Supplement 1). 1831–1831.
2.
McBane, Robert D., Charles L. Loprinzi, Tyler Zemla, et al.. (2024). Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial. Journal of Thrombosis and Haemostasis. 22(6). 1704–1714. 20 indexed citations
3.
Abel, Gregory A., Dana E. Rollison, Nancy Gillis, et al.. (2023). Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study. Blood Advances. 7(14). 3506–3515. 6 indexed citations
4.
Loh, Kah Poh, Megan Wells, Erika Ramsdale, et al.. (2023). Modifiable fall risk factors among older adults with advanced cancer: Secondary analysis of a cluster-randomized clinical trial. Journal of Geriatric Oncology. 14(8). 101650–101650. 1 indexed citations
5.
Loh, Kah Poh, Christopher L. Seplaki, Chandrika Sanapala, et al.. (2022). Association of Prognostic Understanding With Health Care Use Among Older Adults With Advanced Cancer. JAMA Network Open. 5(2). e220018–e220018. 22 indexed citations
6.
Flannery, Marie, Supriya G. Mohile, Eva Culakova, et al.. (2021). Completion of Patient-Reported Outcome Questionnaires Among Older Adults with Advanced Cancer. Journal of Pain and Symptom Management. 63(2). 301–310. 11 indexed citations
7.
Padron, Eric, Steven D. Gore, Nancy Gillis, et al.. (2021). COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study. Blood. 138(Supplement 1). 2611–2611.
8.
9.
Loh, Kah Poh, Enrique Soto‐Pérez‐de‐Celis, Paul R. Duberstein, et al.. (2020). Patient and caregiver agreement on prognosis estimates for older adults with advanced cancer. Cancer. 127(1). 149–159. 18 indexed citations
10.
Iqbal, Syma, Shannon McDonough, Heinz‐Josef Lenz, et al.. (2019). Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201. Journal of Clinical Oncology. 38(5). 472–479. 9 indexed citations
11.
Zhang, Ling, Donald M. Stablein, Pearlie K. Epling‐Burnette, et al.. (2018). Diagnosis of Myelodysplastic Syndromes and Related Conditions: Rates of Discordance between Local and Central Review in the NHLBI MDS Natural History Study. Blood. 132(Supplement 1). 4370–4370. 3 indexed citations
12.
Kamen, Charles, Gwendolyn P. Quinn, Matthew Asare, et al.. (2018). Multimedia psychoeducation for patients with cancer who are eligible for clinical trials: A randomized clinical trial. Cancer. 124(23). 4504–4511. 9 indexed citations
13.
Dalia, Samir, Jane Jijun Liu, Eric Padron, et al.. (2016). Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia. Leukemia Research. 42. 52–58. 5 indexed citations
14.
Liu, Jane Jijun, Mihaela Druta, David Shibata, et al.. (2013). Metabolic syndrome and colorectal cancer: Is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?. Journal of Geriatric Oncology. 5(1). 40–48. 25 indexed citations
15.
Liu, Jane Jijun & Jingsong Zhang. (2013). Sequencing Systemic Therapies in Metastatic Castration-Resistant Prostate Cancer. Cancer Control. 20(3). 181–187. 12 indexed citations
16.
Liu, Jane Jijun & Martine Extermann. (2011). Comprehensive Geriatric Assessment and Its Clinical Impact in Oncology. Clinics in Geriatric Medicine. 28(1). 19–31. 20 indexed citations
17.
Mathew, Rahel, John M. Bennett, Jane Jijun Liu, et al.. (2011). Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leukemia Research. 36(1). 72–80. 53 indexed citations
18.
Liu, Jane Jijun, Ling Zhang, Ernesto Ayala, et al.. (2011). Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: A single institutional experience and literature review. Leukemia Research. 35(12). 1571–1577. 82 indexed citations
19.
Chen, Zuozhou, Weilin Wang, Xuefeng B. Ling, Jane Jijun Liu, & Liangbiao Chen. (2006). GO-Diff: Mining functional differentiation between EST-based transcriptomes. BMC Bioinformatics. 7(1). 72–72. 16 indexed citations
20.
Li, Shuyu, Gene Cutler, Jane Jijun Liu, et al.. (2003). A comparative analysis of HGSC and Celera human genome assemblies and gene sets. Bioinformatics. 19(13). 1597–1605. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew Hantel Breakdown of academic impact, for papers by Lee Mozessohn Breakdown of academic impact, for papers by Pascal Chaı̈bi Breakdown of academic impact, for papers by Benjamin Barnes Breakdown of academic impact, for papers by Roberta Babare Breakdown of academic impact, for papers by Sara Ekberg Breakdown of academic impact, for papers by C.A. Uyl-de Groot Breakdown of academic impact, for papers by O. Gisserot Breakdown of academic impact, for papers by Karen Sweiss
Rankless by CCL
2026